USPTO serial 50200919
TYFERYN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with TYFERYN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Monrovia, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew L. Bycer
Matthew L. Bycer PatentVest, Inc.7220 N. 16th Street, Suite HPhoenix, AZ 85020United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents affecting metabolism; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Ferments for pharmaceutical purposes; Phenol for pharmaceutical purposes; Digestives for pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating hypoglycemia; Diagnostic agents for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Intravenous bags sold filled with phenolic amides; Syringes sold filled with phenolic amides; Therapeutic pharmaceutical for the treatment of metabolic syndrome; Pharmaceutical preparations for the treatment of metabolic syndrome; Biologics in the nature of pharmaceutical preparations for the treatment of metabolic syndrome; Drug delivery agents in the form of oral supplements, injections, topical applications, or inhalation that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment of chronic diseases in the nature of liver disease; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Enzymes for medical purposes; Plant and herb extracts for medicinal purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 4, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 4, 2026 | NWAP | NEW APPLICATION ENTERED | — |